Immune signatures underlying post-acute COVID-19 lung sequelae.
Immune signatures underlying post-acute COVID-19 lung sequelae.
复制标题
DOI:
10.1126/sciimmunol.abk1741
复制
发表时间:
2021-11-12
影响因子:
24.8
通讯作者:
Sun J
中科院分区:
文献类型:
--
作者:
Cheon IS;Li C;Son YM;Goplen NP;Wu Y;Cassmann T;Wang Z;Wei X;Tang J;Li Y;Marlow H;Hughes S;Hammel L;Cox TM;Goddery E;Ayasoufi K;Weiskopf D;Boonyaratanakornkit J;Dong H;Li H;Chakraborty R;Johnson AJ;Edell E;Taylor JJ;Kaplan MH;Sette A;Bartholmai BJ;Kern R;Vassallo R;Sun J
Respiratory tissue resident–like CD8+ T cells are associated with chronic lung sequelae post-acute COVID-19. Severe coronavirus disease 2019 (COVID-19) pneumonia survivors often exhibit long-term pulmonary sequelae, but the underlying mechanisms or associated local and systemic immune correlates are not known. Here, we have performed high-dimensional characterization of the pathophysiological and immune traits of aged COVID-19 convalescents, and correlated the local and systemic immune profiles with pulmonary function and lung imaging. We found that chronic lung impairment was accompanied by persistent respiratory immune alterations. We showed that functional severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)–specific memory T and B cells were enriched at the site of infection compared with those of blood. Detailed evaluation of the lung immune compartment revealed that dysregulated respiratory CD8+ T cell responses were associated with the impaired lung function after acute COVID-19. Single-cell transcriptomic analysis identified the potential pathogenic subsets of respiratory CD8+ T cells contributing to persistent tissue conditions after COVID-19. Our results have revealed pathophysiological and immune traits that may support the development of lung sequelae after SARS-CoV-2 pneumonia in older individuals, with implications for the treatment of chronic COVID-19 symptoms.
登录
查看更多内容
影响因子:
8.8
作者:
Neidleman J;Luo X;George AF;McGregor M;Yang J;Yun C;Murray V;Gill G;Greene WC;Vasquez J;Lee SA;Ghosn E;Lynch KL;Roan NR
通讯作者:
Roan NR
DOI:
10.1126/science.abd4585
发表时间:
2020-10-23
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Bastard P;Rosen LB;Zhang Q;Michailidis E;Hoffmann HH;Zhang Y;Dorgham K;Philippot Q;Rosain J;Béziat V;Manry J;Shaw E;Haljasmägi L;Peterson P;Lorenzo L;Bizien L;Trouillet-Assant S;Dobbs K;de Jesus AA;Belot A;Kallaste A;Catherinot E;Tandjaoui-Lambiotte Y;Le Pen J;Kerner G;Bigio B;Seeleuthner Y;Yang R;Bolze A;Spaan AN;Delmonte OM;Abers MS;Aiuti A;Casari G;Lampasona V;Piemonti L;Ciceri F;Bilguvar K;Lifton RP;Vasse M;Smadja DM;Migaud M;Hadjadj J;Terrier B;Duffy D;Quintana-Murci L;van de Beek D;Roussel L;Vinh DC;Tangye SG;Haerynck F;Dalmau D;Martinez-Picado J;Brodin P;Nussenzweig MC;Boisson-Dupuis S;Rodríguez-Gallego C;Vogt G;Mogensen TH;Oler AJ;Gu J;Burbelo PD;Cohen JI;Biondi A;Bettini LR;D'Angio M;Bonfanti P;Rossignol P;Mayaux J;Rieux-Laucat F;Husebye ES;Fusco F;Ursini MV;Imberti L;Sottini A;Paghera S;Quiros-Roldan E;Rossi C;Castagnoli R;Montagna D;Licari A;Marseglia GL;Duval X;Ghosn J;HGID Lab;NIAID-USUHS Immune Response to COVID Group;COVID Clinicians;COVID-STORM Clinicians;Imagine COVID Group;French COVID Cohort Study Group;Milieu Intérieur Consortium;CoV-Contact Cohort;Amsterdam UMC Covid-19 Biobank;COVID Human Genetic Effort;Tsang JS;Goldbach-Mansky R;Kisand K;Lionakis MS;Puel A;Zhang SY;Holland SM;Gorochov G;Jouanguy E;Rice CM;Cobat A;Notarangelo LD;Abel L;Su HC;Casanova JL
通讯作者:
Casanova JL
影响因子:
2.3
作者:
Bates, JHT;Lutchen, KR
通讯作者:
Lutchen, KR
影响因子:
64.8
作者:
Dudek, Michael;Pfister, Dominik;Knolle, Percy A.
通讯作者:
Knolle, Percy A.
影响因子:
3.3
作者:
Hantos, Z;Petak, F;Fredberg, JJ
通讯作者:
Fredberg, JJ